Timber Pharmaceuticals, Inc.
TMBRAMEXHealthcare
$0.34
+$0.00(+0.74%)
Market Cap$1176057
P/E Ratio—
52W High$3.39
52W Low$0.32
Timber Pharmaceuticals, Inc. (TMBR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TMBR · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: May 15, 2023EPS Actual
-$1.32
Est. -$1.17 · -12.8%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2023
FY ends December
Report Date
May 15, 2023
After Market Close
▼ Miss EPS
TMBR reports quarterly as a AMEX-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 19, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 13, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 29, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 27, 2023 | -$1.26 | — | — | — | — | — |
| ▼ Q2 FY2023 | May 15, 2023 | -$1.17 | -$1.32 | -12.8% | — | $0.00B | — |
| ▼ Q1 FY2023 | Mar 31, 2023 | -$1.50 | -$1.72 | -14.7% | — | $0.00B | — |
| — Q1 FY2023 | Mar 29, 2023 | — | -$1.72 | — | $0.00B | — | — |
| ▼ Q3 FY2022 | Aug 11, 2022 | -$2.00 | -$4.50 | -125.0% | — | — | — |
Q3 FY2024
Aug 19, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 13, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 27, 2023
EPS Actual
—
EPS Est.
-$1.26
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 15, 2023Miss
EPS Actual
-$1.32
EPS Est.
-$1.17
EPS Surpr.
-12.8%
Revenue
—
Q1 FY2023
Mar 31, 2023Miss
EPS Actual
-$1.72
EPS Est.
-$1.50
EPS Surpr.
-14.7%
Revenue
—
Q1 FY2023
Mar 29, 2023
EPS Actual
-$1.72
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 11, 2022Miss
EPS Actual
-$4.50
EPS Est.
-$2.00
EPS Surpr.
-125.0%
Revenue
—
No analyst estimates available for TMBR.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2023 | May 15, 2023 | -12.8% | $0.14 | $0.13 | -1.22% |
| ▼ Q1 FY2023 | Mar 31, 2023 | -14.7% | $0.14 | $0.14 | +3.03% |
| — Q1 FY2023 | Mar 29, 2023 | — | $0.15 | $0.14 | -7.86% |
| ▼ Q3 FY2022 | Aug 11, 2022 | -125.0% | $0.45 | $0.63 | +38.89% |
| ▼ Q2 FY2022 | May 12, 2022 | -25.0% | $1.05 | $1.03 | -1.90% |
| — Q1 FY2022 | Mar 31, 2022 | — | $1.61 | $1.60 | -0.62% |
| — Q4 FY2021 | Dec 31, 2021 | — | $1.69 | $1.58 | -6.51% |
| — Q4 FY2021 | Nov 15, 2021 | — | $2.18 | $2.13 | -2.29% |
Q2 FY2023-1.22%
Report Date
May 15, 2023
EPS Beat/Miss
-12.8%
Price Before
$0.14
Price After
$0.13
Q1 FY2023+3.03%
Report Date
Mar 31, 2023
EPS Beat/Miss
-14.7%
Price Before
$0.14
Price After
$0.14
Q1 FY2023-7.86%
Report Date
Mar 29, 2023
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.14
Q3 FY2022+38.89%
Report Date
Aug 11, 2022
EPS Beat/Miss
-125.0%
Price Before
$0.45
Price After
$0.63
Q2 FY2022-1.90%
Report Date
May 12, 2022
EPS Beat/Miss
-25.0%
Price Before
$1.05
Price After
$1.03
Q1 FY2022-0.62%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$1.61
Price After
$1.60
Q4 FY2021-6.51%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$1.69
Price After
$1.58
Q4 FY2021-2.29%
Report Date
Nov 15, 2021
EPS Beat/Miss
—
Price Before
$2.18
Price After
$2.13
Avg Miss Reaction+9.70%
Beat Rate0 / 8 quarters
Largest Move+38.89% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TMBR ends December
Timber Pharmaceuticals, Inc. (TMBR) most recently reported earnings on May 15, 2023 for Q2 FY2023, posting EPS of $-1.32 — missing the analyst consensus of $-1.17 by -12.8%. The next TMBR earnings date is expected around September 1, 2026.
Each quarter, investors track TMBR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TMBR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TMBR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TMBR earnings · 5 questionsTimber Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. TMBR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TMBR historically reports after market close (AMC).
TMBR earnings datewhen is TMBR earningsTMBR next earnings datewhen does TMBR report earningsTMBR earnings calendar
▸ Source: FMP · Timber Pharmaceuticals, Inc. SEC filings · US GAAP · Timber Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026